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ABSTRACT 
Background: Information about voice use outside the clinical setting has traditionally 
consisted of subjective data collected via interviews or questionnaires. Quantitative, objective 
information about voice use in daily life could increase our understanding of the challenges 
faced by patients outside the controlled clinical environment. There is a high prevalence of 
hypophonia in individuals with Parkinson’s disease (PD). Objective information regarding 
voice use would be of value, not the least for this population considering the changes in 
perception of speech production and cognition found in PD, and may be collected with the 
use of a portable voice accumulator 
Objectives: The aim of this thesis was to study voice use and communication in daily life in 
individuals with PD and healthy matched controls using a portable voice accumulator.  A 
further aim was to assess the outcome following biofeedback intervention provided with a 
portable voice accumulator with the goal to increase voice sound level in daily life for 
individuals with hypophonia related to PD.   
Materials and methods: In study I, the portable voice accumulator VoxLog was used to 
monitor voice use in daily life regarding voice sound level and phonation ratio in different 
levels of environmental noise for twenty-one individuals with PD and twenty-one matched 
healthy controls during a week-long registration period. In study II, treatment outcome 
following Lee Silverman Voice Treatment (LSVT LOUD®) was assessed in a pseudo-single 
case study through monitoring of voice use in daily life before, during, and after treatment as 
well as at follow-up one year after treatment. In study III, the portable voice accumulator 
VoxLog’s biofeedback function was used to provide biofeedback intervention during one 
week for six individuals with PD with the goal to increase voice sound level in daily life. 
Study IV focused on experimentally testing the biofeedback function of the VoxLog to 
assess how different feedback frequencies can be achieved by adjusting the available settings. 
Six different biofeedback settings were assessed during semi-structured conversations with 
twenty participants. In study V, a four-week long biofeedback intervention period was 
evaluated for eight individuals with PD. Voice use was monitored the week before 
intervention, during the four-week intervention period, the week after intervention and one 
week at follow-up, three months post intervention.  
Results: Seventy-eight participants were included in the analysis and field registrations were 
performed for a total of 127 weeks in the project. The week-long registrations of voice use in 
study I showed that individuals with PD use their voice 50-60% less than their matched 
healthy controls. The difference increased in situations with loud environmental noise, which 
in many cases are social situations. A difference in mean voice sound level was found where 
individuals with PD used a voice sound level 6-8 dB lower than their matched healthy 
controls. Voice sound level used in daily life differed significantly from the voice sound level 
during controlled studio registrations for both the male and female groups. Study II showed 
that the changes in voice sound level after LSVT LOUD® when studied in daily life with a 
portable voice accumulator reflect earlier reported changes registered during controlled studio 
  
recordings. In study III, a significant increase in voice sound level in relation to the 
environmental noise was found during the intervention week but the effect did not remain 
when the biofeedback was removed. Based on the findings in study IV, a systematic 
procedure to configure the biofeedback settings in the VoxLog was recommended to achieve 
a low feedback frequency, known to facilitate retention after training in the motor learning 
literature. The results from study V showed an increase in voice sound level in relation to the 
environmental noise following a four-week long biofeedback intervention and the effect was 
still present at the three-month follow-up. Results from screening with the Montreal 
Cognitive Assessment showed that individuals who scored above the cut-off for mild 
cognitive impairment had more positive and lasting outcomes compared to the group who 
scored below the cut-off for mild cognitive impairment.  
Conclusions: Objective assessment of voice use in daily situations outside a controlled 
clinical setting is a valuable complement to traditional methods and can increase the 
ecological validity of our assessments. Providing biofeedback to help individuals with 
hypophonia secondary to PD increase their voice sound level may be an alternative or 
complement to voice therapy performed at a clinic. Further research with more participants is 
however needed to determine the efficacy of this intervention approach, and development of 
the biofeedback capabilities of portable voice accumulators are needed to improve the 
method.  
  
 SAMMANFATTNING 
Bakgrund: Information om röstanvändning utanför kliniken inhämtas traditionellt från 
intervjuer eller frågeformulär. Objektiv och kvantifierbar information om röstanvändning i 
vardagen skulle kunna öka kunskapen om de utmaningar som patienter med röststörningar 
möter utan för den kontrollerade klinikmiljön. Det är mycket vanligt att röststyrkan blir 
nedsatt hos personer med Parkinsons sjukdom. Objektiv information om röstanvändning kan 
inhämtas med hjälp av bärbara röstackumulatorer och skulle vara av stor nytta för 
patientgruppen då förändringar i hur den egna rösten uppfattas och kognitiv svikt är vanligt 
relaterat till sjukdomen.  
Syfte: Målet med denna avhandling var att studera hur röstanvändning och kommunikation 
påverkas i vardagen för personer med Parkinsons sjukdom jämfört med matchade röstfriska 
kontrollpersoner med hjälp av en bärbar röstackumulator. Ett ytterligare mål var att utvärdera 
effekten av en intervention där individer med Parkinsons sjukdom får kontinuerlig 
återkoppling i vardagen gällande talets röststyrka med målet att hjälpa dem höja röststyrkan.  
Material och metoder: Sammanlagt sjuttioåtta deltagare ingår i analysen och materialet 
omfattar totalt 127 veckor av långtidsregistrering av röstanvändning i vardagen. I studie I 
användes röstackumulatorn VoxLog för att registrera röstanvändning i vardagen avseende 
röststyrka och fonationstid under en vecka för tjugotvå deltagare med Parkinsons sjukdom 
och tjugotvå matchade, röstfriska kontrollpersoner. I studie II utvärderades effekten av Lee 
Silverman Voice Treatment i en fallstudie där röstanvändning registrerades med 
röstackumulator före, under och efter behandling samt vid uppföljning upp till ett år efter att 
behandlingen avslutats. I studie III användes röstackumulatorn VoxLogs 
återkopplingsfunktion i träningssyfte där sex personer med Parkinsons sjukdom fick 
kontinuerlig återkoppling avseende röststyrka under en veckas tid med målsättningen att höja 
röststyrkan i vardagen. Studie IV fokuserade på att experimentellt utvärdera de 
återkopplingsinställningar som går att justera i mjukvaran för att uppnå en önskad 
återkopplingsfrekvens. Sex olika återkopplingsinställningar testades under semistrukturerade 
konversationer med tjugo deltagare. I studie V utvärderades en fyra veckor lång 
återkopplingsperiod för åtta individer med Parkinsons sjukdom. Röstanvändning 
registrerades veckan före intervention, under de fyra veckorna då återkoppling gavs, en vecka 
efter intervention samt en vecka vid uppföljning tre månader efter interventionsperioden.  
Resultat: Resultaten från den veckolånga registreringen av röstanvändningen i studie I 
visade att deltagarna med Parkinsons sjukdom använder sin röst 50 - 60 % mindre än 
matchade röstfriska kontrollpersoner. Skillnaden ökade i miljöer med högt bakgrundsbuller, 
vilket i många fall är sociala situationer. En skillnad i genomsnittlig röststyrka sågs där 
personer med Parkinsons sjukdom använde en röststyrka som var 6 - 8 dB lägre än den 
röstfriska kontrollgruppen. Röststyrkan som användes i vardagen skiljde sig signifikant från 
röststyrkan som användes under kontrollerade registreringar i studiomiljö för alla grupperna. 
  
I studie II visades en ökad röststyrka under röstanvändning i vardagen efter Lee Silverman 
Voice Treatment som motsvarade tidigare rapporter baserade på kontrollerade inspelningar i 
studiomiljö. I studie III fann man en ökad röststyrka i relation till omgivande buller under 
interventionsveckan men effekten kvarstod inte när återkopplingen inte längre 
administrerades. Utifrån resultaten i studie IV rekommenderas en systematisk process för att 
välja återkopplingsinställningar när man använder VoxLog för att uppnå en låg 
återkopplingsfrekvens vilket främjar en bestående inlärning enligt tidigare forskning om 
motorisk inlärning. Resultaten från studie V visade en ökad röststyrka i relation till 
bakgrundsbuller under röstanvändning i vardagen efter fyra veckors intervention med 
återkoppling avseende röststyrka. Effekten var kvarstående vid uppföljning efter tre månader. 
Testning med screeningmaterialet Montreal Cognitive Assessment visade att deltagare som 
presterade över gränsvärden för mild kognitiv svikt uppnådde bättre och mer bestående 
resultat efter interventionen än deltagare som presterade under gränsvärdena för mild kognitiv 
svikt.  
Slutsatser: Objektiv bedömning av röstanvändning i vardagen utanför en kontrollerad miljö 
är ett värdefullt komplement till traditionella metoder och kan öka den ekologiska validiteten 
av röstanalyser. Möjligheten att ge kontinuerlig återkoppling på röststyrka i vardagen för 
personer med Parkinsons sjukdom för att hjälpa dem höja sin röststyrka kan vara ett effektivt 
alternativ eller komplement till traditionell röstbehandling. Fortsatt forskning med flera 
deltagare krävs dock för att säkert fastställa nyttan av metoden. Utvecklande av 
återkopplingsfunktionen i framtidens bärbara röstackumulatorer skulle även stärka metoden. 
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1 INTRODUCTION 
Being able to participate in social interaction and communicate freely is one of the most 
important aspects of our daily life. Eadie and colleagues (2006) define communicative 
participation as taking part in life situations where knowledge, information, ideas or 
feelings are exchanged. For many, the ability to communicate is taken for granted until one 
finds itself in a situation where we are not able to do so effectively. Problems with 
communication can be, for example, the frustration caused by a distorted message due to 
bad phone connection or losing your voice due to a cold. In most cases, the communication 
breakdowns are transient, a problem easily overcome. The problems can however also be 
more severe, and in some cases permanent. Communication difficulties can also originate 
from an impairment related to a disease or be of a developmental nature, often described as 
a communication disorder.  
The American Speech-Language-Hearing Association (1993) defines a communication 
disorder as “an impairment in the ability to receive, send, process and comprehend concepts 
or verbal, nonverbal and graphic symbol systems. A communication disorder may be 
evident in the processes of hearing, language and/or speech. A communication disorder 
may range in severity from mild to profound. It may be developmental or acquired. 
Individuals may demonstrate one or any combination of the three aspects of communication 
disorders. A communication disorder may result in a primary disability or it may be 
secondary to other disabilities”. A communication disorder can, as one might imagine, 
present itself in many ways. Communication disorders secondary to neurological disease is 
one common example.  
 
1.1 PARKINSON’S DISEASE 
1.1.1 Etiology and symptoms 
Parkinson’s disease (PD) is a neurodegenerative disease resulting from a loss of 
dopaminergic neurons in the brain, mainly the basal ganglia, which in turn leads to a 
dopamine deficiency. It is one of the most common neurological disorders and the fastest 
growing in terms of increasing prevalence globally (GBD 2016 Parkinson’s Disease 
Collaborators, 2018; Rossi et al 2018). The neuromuscular deficits following the dopamine 
loss in the brain result in a restriction of range and speed of movements, leading to a variety 
of motor symptoms. The main gross motor symptoms include rest tremor, rigidity, 
bradykinesia and postural instability. Speech and voice are also commonly affected in PD. 
Hypokinetic dysarthria is the subtype of dysarthria associated with PD, and can occur as 
one of the first symptoms, but may also present itself several years after PD onset (Duffy, 
2013). In autopsy-confirmed cases of PD, approximately 90% showed signs of dysarthria 
during the disease progression (Müller et al., 2001).  
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The most common symptom of hypokinetic dysarthria is reduced voice intensity. Fox and 
Ramig (1997) performed a comparison of voice intensity during various speech tasks in a 
controlled environment between individuals with PD and healthy controls. For the PD 
group, they found a voice intensity that was 2-4 dB lower, which the authors equated to a 
40% reduction in vocal loudness. Other symptoms include imprecise articulation, 
monopitch and intensity, breathiness, hoarseness and variable speech rate (Duffy, 2013). 
Cognitive and psychiatric symptoms are also common in PD, including dementia, 
depression, disturbed sleep patterns and hallucinations (Duffy, 2013). Speech motor deficits 
impacting intelligibility, combined with cognitive and psychiatric changes, can lead to 
major limitations in communicative participation and social interactions (Miller et al., 2006; 
Hartelius et al., 2008; Baylor et al., 2011; Schalling et al., 2017; Yorkston et al., 2017). 
Miller et al. (2006) performed in-depth interviews with 37 men and women with PD about 
how communication had been changed as a result of their disease. Their main concern was 
not how their speech and voice had been altered, but rather how these changes affected 
their concept of self and their ability to participate in social situations. Social withdrawal 
was a recurring example, in some cases from being shut out of conversations as a result of 
an inability to keep up with the other speakers; and also as a coping strategy to preserve 
strength and make sure that they would be able to say something if it really mattered.  
 
1.1.2 Pharmacological treatment 
There are no curative treatment options for PD, but there are several options available to 
alleviate motor symptoms. Pharmacological treatment mainly focuses on increasing the 
dopamine levels in the brain and generally produce good results regarding gross motor 
function, especially during earlier stages of the disease progression. Over time, side-effects 
such as dyskinesias are common. Maintaining a consistent medication response is a 
challenge for many as the disease progresses, and on-off effects are common. This can 
result in symptom fluctuations during the beginning, peak or end of a dosage cycle. 
Furthermore, the effects on dysarthria are limited and variable. Some studies have shown a 
positive effect of pharmacological intervention on specific speech and voice parameters (De 
Letter, Santens, de Bodt et al., 2007; De Letter, Santens, Estercam et al., 2007; Ho et al., 
2008; Skodda, 2010) whereas other studies have shown no improvement, particularly 
regarding changes in voice sound level (Ramig et al., 2007; Plowman-Prine et al., 2009; 
Pinho et al., 2019). 
 
1.1.3 Surgical treatment 
Surgical treatment options such as Deep Brain Stimulation (DBS) have become 
increasingly common during the last decade. Electrodes are surgically implanted to 
continuously stimulate specific targets in the brain. DBS is not a standard treatment option 
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but is often considered in advanced stages of the disease, when pharmacological treatment 
is less effective and more difficult to manage (Breit et al., 2004). The effect of DBS varies 
depending on the locus being stimulated and how the electrical stimulation is administered. 
Common targets include the subthalamicus nucleus (STN DBS) (Benabid, 2003), globus 
pallidus pars interna (GPi DBS) (Rodriguez-Oroz et al., 2005) and the caudal zona incerta 
(cZi DBS) (Plaha et al., 2006). The impact on speech varies, and may even be negative 
(Pinto et al., 2005; D’Alatri et al., 2008; Klosterman et al., 2008; Karlsson et al., 2011; 
Karlsson et al., 2012; Schulz et al., 2012; Karlsson et al., 2013; Karlsson et al., 2014; 
Sandström et al., 2016). 
 
1.1.4 Speech and voice treatment 
Behavioral treatment approaches provided by speech and language pathologists (SLPs) are 
the leading treatment options for speech and voice symptoms today, as pharmacological 
and surgical treatments have a limited and variable effect (Atkinson-Clement et al., 2015). 
The historical view that speech changes in PD may be resistant to behavioral intervention 
(Weiner & Singer, 1989) has changed over the last decades, as several studies have shown 
positive and lasting changes after behavioral intervention (Ramig et al., 2001; Sapir et al., 
2011; Fox et al., 2012; Atkinson-Clement et al., 2015; Watts, 2016; Ramig et al., 2018). 
The treatment option with the strongest evidence today is the Lee Silverman Voice 
Treatment (LSVT LOUD®), with reported positive outcomes regarding increased voice 
intensity for up to two years after treatment (Ramig et al., 2001; Sapir et al., 2011; Fox et 
al., 2012; Ramig et al., 2018). It is an intensive treatment program, focusing on increasing 
effort to increase voice intensity. The treatment program consists of sixteen individual 
hour-long treatment sessions administered over four weeks. In addition, daily exercises are 
performed by the patient at home. The exercise program includes tasks such as maximum 
sustained phonation and production of functional phrases with a loud voice, and 
hierarchically structured speaking exercises aimed at rescaling subjectively needed effort to 
produce adequate intensity during speech.  
Despite the positive changes during clinical follow-up assessment after intensive voice 
treatment, there are still many patients that struggle with the carryover of treatment effect to 
their habitual speech outside the clinical setting. This might be explained by the changes in 
sensory perception reported for individuals with PD, which could lead to an 
underestimation of required effort when speaking (Ho et al., 2000). A possibly impaired 
ability to regulate and scale intensity and range of motor functions in PD could also be a 
contributing factor (Klockgether et al., 1995; Demirci et al., 1997). Deficits in internal 
cueing have also been suggested as a factor, which could create difficulties adjusting voice 
intensity in response to implicit cues, whereas external cues used during treatment still can 
be used efficiently (Ramig et al., 2007). A way to facilitate a more successful carryover of 
treatment effects could be to provide continuous biofeedback on voice use in daily life. 
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1.2 TRADITIONAL METHODS TO RECORD SPEECH 
Assessment and analysis of speech and voice function is traditionally based on standardized 
clinical assessment tools and audio recordings made in controlled environments. Speech 
tasks used during controlled recordings typically include spontaneous speech, reading of 
words, sentences and text, as well as more specific tasks such as sustained phonation, which 
can be used for both perceptual assessment and acoustic analysis (Duffy, 2013). The 
motivation for making standardized recordings in a controlled environment is to ensure a 
reliable and replicable assessment, which is important both for research purposes and for 
clinical work, e g for comparson of function before and after treatment. Voice use during 
such controlled tasks and settings might however differ greatly from voice use during 
habitual speech in daily life. In such uncontrolled and varying settings there are many 
factors that can affect the speaker, and the requirements and challenges imposed on the 
voice increase. Environmental noise, stress, physical movement, emotional state as well as 
the cognitive load of participating in a conversation, which increases with topic complexity, 
introduce challenges that are not comparable to the situation during controlled recordings. 
Patients’ subjective descriptions through interviews or standardized self-report 
questionnaires are often used to include assessment of factors affecting the voice, but 
reports of subjective experiences of voice use are not necessarily reliable. A more 
ecologically valid approach to assessment of speech and voice could be to study voice use 
outside a clinical setting objectively, using wearable devices with the ability to register 
important speech and voice parameters (Mehta et al., 2015). 
 
1.3 AMBULATORY MONITORING OF VOICE USE 
1.3.1 Methods for monitoring of voice use outside a clinical setting 
Wearable devices with the ability to monitor health parameters have been popularized and 
made available to the general public in recent years, for instance in the form of 
smartwatches. Such technical aids could be a revolutionary addition to speech and voice 
assessment, as they can allow for real-time monitoring of voice use in daily life settings. 
Methods to monitor voice use in daily life have been used in research for several decades, 
see Szabo Portela (2017) for a review. The clinical availability of such methods has 
however been very limited. There have been three such devices commercially available to 
clinicians in different iterations, commonly referred to as portable voice accumulators 
(PVAs) (Van Stan et al., 2014): the VoxLog (Sonvox AB, Umeå, Sweden), the Ambulatory 
Phonation Monitor (KayPentax, NJ, USA) and the Vocalog (Griffin Laboratories, CA, 
USA). There have also been recent ongoing attempts to develop wearable devices to 
monitor voice and speech function, currently in a research phase at the time of writing, 
including a low-cost device based on existing hardware (Hunter, 2013), a smartphone-based 
device (Mehta et al., 2015), a smartwatch-based device (Mahler et al., 2016) and a 
standalone accelerometer-based device (Astolfi, 2016a; Astolfi, 2016b). 
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The VoxLog, Ambulatory Phonation Monitor and Vocalog are in many ways similar in 
methodological approaches and functions, but they differ in a couple of key aspects 
(Wirebrand, 2012). All devices consist of a neck-mounted sensor that is connected to a 
wearable device, where data is processed, stored and later uploaded to a computer for 
analysis in the accompanying software. The Ambulatory Phonation Monitor uses an 
accelerometer to detect the vocal fold vibrations during phonation. It can register 
fundamental phonation frequency (Hz), time spent phonating (%) and, through a calibration 
procedure that needs to be repeated before each monitoring session or when the sensor is 
displaced, it can estimate voice intensity (dB SPL). The Vocalog uses a similar 
accelerometer method to estimate voice sound level (dB) and to register time spent 
phonating. The VoxLog uses a combined approach with an accelerometer and a 
microphone. The accelerometer is used to register fundamental phonation frequency (Hz) 
and time spent phonating. When the accelerometer detects phonation, the sound pressure 
level that the microphone transduces is registered as the wearer’s voice intensity (dB). 
When no phonation is detected by the microphone, the input level is registered as the level 
of environmental noise (dB). No calibration is needed for the VoxLog, as it registers voice 
intensity and level of environmental noise at the actual distance from the microphone to the 
source. Together with van Stan and colleagues (2014), a comparison study of these devices 
has been published which focuses on how their differences in function could impact choice 
of method used in clinical work; see table 1 below for important differences. All these 
devices register different aspects of voice function, but do not record the speech signal, 
which protects the integrity of the wearers and their conversational partners. 
 
Table 1 Description of the characteristics for each of the three commercially available devices (van Stan et al., 
2014). 
Variables APM VoxLog Vocalog 
Voice sound level (dB) × × × 
Biofeedback (voice sound level, dB) × × × 
Fundamental frequency (Hz) × ×  
Biofeedback fundamental frequency (Hz) × ×  
Percent phonation (%) × × × 
Environmental noise (dB)  ×  
Need for dB SPL Calibration Daily None Once 
Max registration duration* 18 hours 7 days 3 weeks 
* Maximum registration duration before data needs to be exported to a computer before further registration is 
possible. 
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All three commercially available PVAs described above can provide direct biofeedback 
regarding the wearer’s voice intensity. The VoxLog and the Ambulatory Phonation Monitor 
can also provide biofeedback regarding fundamental frequency. The biofeedback can be 
delivered in the form of a vibration from the device, worn in the belt or in a pocket, when 
the speaker goes above or below an adjustable threshold level. In the case of patients with 
PD, the biofeedback function may be used as a therapeutic device to remind the patient 
with PD to increase his or her voice intensity in their daily life. 
 
1.3.2 Applications in Parkinson’s disease 
Individuals with PD commonly report that they feel they have become more withdrawn in 
social situations as a result of their disease (Miller et al., 2006; Schalling et al., 2017). 
Monitoring phonation time during habitual speech in daily life could make a valuable 
contribution to the understanding of the impact of PD on communicative participation. The 
ability to register voice intensity without calibration and the ability to register level of 
environmental noise makes the VoxLog the ideal PVA to use when the goal is to monitor 
voice use in patients with PD, as a decreased voice intensity is one of the major voice 
symptoms and an increased voice intensity is often the main goal of intervention. 
Environmental noise is known to impact voice intensity: speakers have been shown to 
habitually increase their voice intensity in increasing levels of environmental noise. This is 
commonly referred to as the Lombard effect or the Lombard sign (Lombard, 1911). It is 
therefore important to be able to control for variations in environmental noise when, for 
example, evaluating treatment outcome focusing on increased voice intensity with a PVA. 
The Lombard effect and how a speaker habitually changes voice intensity depending on 
environmental noise and speech task have been studied extensively historically (Gardner, 
1964; Gardner, 1966; Hanley & Steer, 1949; Korn, 1954; Pickett, 1958; Webster & 
Klumpp, 1962). Lane and Tranel (1971) described in a review that a speaker generally 
increases his/her voice intensity in relation to increasing environmental noise as a function 
of 0.5, with some variation depending on task and setting. Speech in a setting where the 
environmental noise increases with 6 dBA would generally lead to an increased voice 
intensity of 3 dB SPL.  
The guidelines for speech in noise presented by the Swedish Work Environment Authority 
describe that a speaker will start to increase the voice intensity when the level of 
environmental noise starts to go above 40 dBA. A normal voice intensity is still intelligible 
at a distance of 1 meter when the level of environmental noise is 55 dBA. A loud voice is 
needed to be intelligible at a distance of 1 meter when the level of environmental noise 
reaches 70 dBA and a speaker needs to shout or scream to be intelligible in a level of 
environmental noise of 85 dBA (Arlinger, 1999).  
There have been several studies that have looked at how variations in environmental noise 
affect speech regulation, in individuals with PD in particular (Adams & Lang, 1992; Ho et 
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al., 1999; Dromey et al., 2000; Sadagopan & Huber, 2007; Stathopoulos et al., 2014). On a 
group level, individuals with PD have been shown generally to react to increased levels of 
environmental noise in a way similar to healthy speakers. There are however exceptions 
within the groups where individuals with PD fail to regulate voice intensity in response to 
variations in the levels of environmental noise (Sadagopan & Huber, 2007; Stathopoulos et 
al., 2014). The variability may be a result of individual differences in the ability to regulate 
intensity, be it related to skill or severity of dysarthria. It could also be due to the fact that 
the levels of environmental noise imposed on the speaker differed between some studies. 
 
1.3.3 Biofeedback in speech and voice intervention 
It is common practice to deliver feedback on performance during behavioral speech and 
voice treatment using verbal cues or by prompting patients to react to kinesthetic or 
auditory internal cues. Other approaches, such as delivering feedback through external 
technical aids to enhance learning during voice intervention have also been used. These 
include a variety of methods such as visual biofeedback (Scott & Caird, 1983; Laukkanen 
Syrjä, Latala & Leino, 2004; Norrlinder & Olsson, 2009; Schneider-Stickler, Knell, 
Aichstill & Jocher, 2012; Kearney et al., 2018), auditory biofeedback (Sadagopan & Huber, 
2007), combined auditory and visual biofeedback (Le Dorze, Dionne, Ryalls, Julien & 
Oullet, 1992) as well as tactile biofeedback (Hauser, 2005; Van Stan, Mehta & Hillman, 
2015). Reported results are generally positive, but in most cases, results regarding retention 
were not reported. In addition, knowledge regarding principles of motor learning and how 
they may relate to practice and delivery of feedback is seldom incorporated in the study 
design.  
 
1.4 MOTOR LEARNING THEORY 
1.4.1 Principles of motor learning 
Schmidt and Lee define motor learning as a set of processes associated with practice or 
experience leading to relatively permanent changes in the capability for movement 
(Schmidt & Lee, 2005). Learning can be roughly divided into two phases; acquisition and 
retention. The acquisition phase closely adheres to the training period. Changes in 
performance during, or directly after, practice are considered to be related to the acquisition 
phase. The retention phase, on the other hand, occurs after a period without practice. The 
amount of time needed to separate the acquisition and retention phase is not clearly 
established in the literature and can lead to varying interpretations of learning outcomes 
(Soderstrom & Bjork, 2015). Changes in performance observed hours, days, or preferably 
weeks or months after practice could be seen as evidence of retention of a learned behavior. 
Kantak and Winstein (2012) performed a review of the motor learning literature where 
learning outcome based on different practice and feedback conditions and both immediate 
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(same day) and delayed (>24 h) retention tests had been performed after the practice period. 
In 63% of the included studies (n = 41) there were inconsistent results between the 
immediate and delayed retention test. In 73% of the studies with inconsistent findings a 
significant difference between the different practice/feedback conditions could only be seen 
during the delayed retention test. Although not conclusive, their finding could be used as a 
basis for recommending that retention tests should be performed at least 24 hours after the 
end of practice to ensure that it is retention and not performance during acquisition that is 
being assessed. The different conditions of practice and different types of feedback that 
have been shown to affect the learning outcome are referred to as principles of motor 
learning. The primary principles of motor learning commonly described in motor learning 
literature are summarized in table 2.  
 
Table 2. Summary of the primary principles of motor learning (Bislick, Weir, Spencer, Kendall & Yorkston, 
2012). Italicized principles represent those that better facilitate retention of learned motor skills in contrast to 
improved acquisition with the exception of high number of trials which promotes both retention and acquisition. 
Structure of Feedback Structure of Practice 
Knowledge of performance  
(feedback regarding specific aspects of the trial 
outcome) 
Massed practice  
(practice in a short period of time) 
Knowledge of results  
(feedback regarding correctness of the trial outcome) 
Distributed practice  
(practice over a long period of time) 
High-frequency feedback  
(I e, feedback after every trial) 
Blocked practice  
(different targets in discrete blocks) 
Low-frequency feedback  
(I e, feedback after several attempts) 
Random practice  
(different targets are presented randomly) 
Immediate feedback  
(feedback immediately following each trial) 
Constant practice  
(practice in the same context) 
Delayed feedback  
(feedback provided with a delay) 
Varied practice  
(practice in different contexts) 
 Low number of trials 
 High number of trials 
 
While motor learning has been studied extensively regarding gross motor function in 
general and limb motor function in particular, the research on speech motor learning is still 
somewhat limited. The interest and the amount of research being performed in the area 
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have however increased greatly in the last ten years (Bislick et al., 2012; Friedman, 
Hancock, Bamdad & Schulz, 2010; Iwarsson, 2015; Maas et al., 2008). The need to 
develop more structured and efficient treatment programs for childhood apraxia of speech 
has been a driving factor for some of the work (Hula, Robin, Maas, Ballard & Schmidt, 
2008; Katz, McNeil & Garst, 2010; Maas, Barlow, Robin & Shapiro,2002; Maas, 
Gildersleeve-Neumann, Jakielski & Stoeckel, 2014; Preston, Leese & Maas, 2016). Other 
populations have been studied as well, including healthy speakers (Adams & Page, 2000; 
Kaipa, 2016; Steinhauer & Grayhack, 2000), individuals with PD (Adams & Page, 2000; 
Adams, Page & Jog, 2002) and aphasia (Knock, Ballard, Robin & Schmidt, 2000). 
Although limited, studies on applying principles on motor learning on speech motor 
learning have generally been promising in regard to confirming findings from the non-
speech-motor learning literature. 
 
1.4.2 Delivering feedback with a portable voice accumulator 
By using a portable voice accumulator to deliver biofeedback, many of the general 
principles of motor learning that have been shown to facilitate a strong retention of a 
learned motor skill can be applied. The practice can easily reach a high number of trials as 
each utterance could constitute a trial. Practice can also be distributed over long periods of 
time. It can be randomized, as habitual speech can provide different and unique speech 
targets during conversation, or varied, depending on the context of the activities in which 
the speaker participates. The feedback that the available PVA:s deliver is provided in the 
form of knowledge of results. Their biofeedback activation signals only an incorrect 
production, such as too low a voice sound level. Depending on how the available adjustable 
biofeedback settings are configured, it would also be possible to provide low-frequency 
feedback. Of those components of motor learning described above that facilitate retention, 
delayed feedback is the only feature that cannot be provided by the PVA:s in their current 
form. The biofeedback signal occurs immediately after a trial and cannot be configured to 
be delayed. 
 
1.4.3 Motor learning in Parkinson’s disease 
The capacity for motor learning in individuals with PD has been an area of significant 
interest for many years, since the basal ganglia have been shown to play a role in motor 
learning (Brasted & Wise, 2004; Graybiel, 1995; Graybiel, 2005). Findings have been 
inconsistent over the years, with earlier claims that acquisition and retention of motor skills 
might be impaired in PD (Agostino et al., 2004; Schulz, Sulc, Leon & Gilligan, 2000; 
Weiner & Singer, 1989). More recent studies have however reported results that show an 
intact motor learning potential for individuals with PD (Pendt, Reuter & Müller, 2011; 
Petzinger et al., 2013), but they might need increased practice through a higher number of 
trials and longer training periods (Niewboer, Rochester, Müncks &Swinnen, 2009). 
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As mentioned above, the feedback frequency is the main component of motor learning that 
can be directly configured in the PVAs available today. As with healthy individuals, in 
individuals with PD a reduced frequency of feedback has been shown to improve learning 
of a novel limb motor skill (Chiviacowsky, Campos & Domingues, 2010; Onla-or & 
Winstein, 2008), as well as of a speech task consisting of a reduced speech rate (Adams & 
Page, 2000; Adams et al., 2002). Contradictory findings were reported by Guadagnoli, Leis, 
Van Gemmert & Stelmach (2002) where the difference between 20% and 100% feedback 
was studied during training of a simple limb motor task. Twenty individuals with PD and 
20 healthy controls where included in the study. Hundred percent feedback was reported to 
result in the greatest improvement in performance during retention tests; this differs from 
previous findings. However, the retention tests were carried out only 15 minutes after the 
end of practice, which might not be a sufficient time interval to separate acquisition from 
retention (Kantak & Winstein, 2011). The results could therefore be seen as confirming 
previous findings that a high-frequency feedback improves performance during the 
acquisition phase. 
 
1.5 AIMS OF THE THESIS 
The overarching aim of this thesis project was to increase the knowledge of how voice use 
and communication is affected in the daily life of individuals with PD. This included studying 
voice use as well as treatment outcomes in daily life using a portable voice accumulator in 
contrast to controlled studio environments. The aim was also to evaluate the biofeedback 
function available in the portable voice accumulator VoxLog as a possible alternate or 
complementary treatment option for individuals with PD and related hypophonia.  
More specifically, the purpose was to:   
- Compare voice use between patients with PD and matched healthy controls, both in 
daily life and in controlled studio environments. (Study I) 
- Evaluate the treatment outcome in daily life of the leading speech and voice treatment 
(LSVT LOUD®). (Study II) 
- Experimentally evaluate the biofeedback function available in the portable voice 
accumulator VoxLog, based on principles of motor learning. (Study IV) 
- Evaluate the outcome following continuous biofeedback of voice sound level in 
habitual speech in daily life as a treatment alternative. (Study III & V) 
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2 MATERIALS AND METHODS 
2.1 PARTICIPANTS AND RECRUITMENT 
A summary of all 78 participants (56 individuals with PD and 22 healthy controls) included 
in the thesis is presented in table 3. Inclusion criteria for all participants with PD in study I-
V were: diagnosis of idiopathic Parkinson’s disease, subjective speech and voice symptoms 
and PD related hypokinetic dysarthria assessed by a speech and language pathologist. An 
additional criterion was that the participant or their partner should have no severe hearing 
impairment, as this would be expected to have an impact on the general voice sound level 
used. 
 
Table 3. Participant characteristics for study I-V. 
 n PD  
(male/female) 
n Controls 
(male/female) 
Mean age PD 
(male/female) 
Mean age Control 
(male/female) 
 
Study I 21 (11/10) 21 (11/10) 65.8 (66.6/65.0) 67.2 (68.0/66.4)  
Study II 1 (1/-) 1 (1/-) 51.0  51.0  
Study III 6 (5/1) 0 68.6 (69.6/64.0)   
Study IV 20 (13/7) 0 68.1 (69.2/66.1)   
Study V 8 (8/0)* 0 72.0   
*Sixteen participants were originally included. 
 
The participants with PD were recruited through their clinical speech and language 
pathologist contact and through a national patient organization for individuals with PD. The 
control participants in study I where recruited through local retiree organizations and through 
the social networks of the individual’s with PD. All participants underwent pharmacological 
treatment for their PD that was unchanged during the study period. 
The inclusion criteria for the control group included no subjective voice symptoms, 
assessed with the Swedish version of the Voice Handicap Index (Ohlsson & Dotevall, 
2009) with a cut-off-value of <20, no neurological disease with related speech or voice 
disorders and no severe hearing impairment for them or their partner. 
Study II was initially planned as an intervention study to assess treatment outcome after 
LSVT LOUD® for a group of individuals with PD. The study design was however revised 
as a pseudo-single case design to allow for a more reasonable time frame within the 
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doctoral project. Participants were one individual with PD and one matched healthy control 
who was the patient’s monozygotic twin. Their work and living conditions were similar, 
both living with a spouse and teenage children and working in manager positions with high 
demands on voice function. 
Sixteen individuals were included and began participation in study V. During the 
participation period seven participants ended their participation early due to various reasons 
including the opportunity to receive in-patient rehab and sudden travel plans. Difficulties 
understanding how they should use the device and respond to the feedback was mentioned 
in a few cases and in some cases no reason was given as to why they wanted to withdraw 
from the study early. One of the eight participants who completed the program was female. 
As differences in voice function can be expected between men and women this participant 
was excluded from the analysis to allow assessment on a group level.  
 
2.2 ASSESSMENT METHODS 
2.2.1 The VoxLog 
The VoxLog (firmware 2.2.3) is a portable voice accumulator, shown in figure 1, a device 
that enables long-term registration of voice use in daily life (Wirebrand, 2012). The 
VoxLog can register fundamental frequency, phonation ratio (percent time spent phonating 
during registration), voice sound level (dB) and the level of the background noise (dB). An 
accelerometer in combination with a microphone mounted in a plastic neck collar is used to 
detect phonation and monitor the voice parameters. The neck collar is connected to a box 
that can be worn in a pocket. During phonation, the device derives the fundamental 
frequency and phonation ratio from the skin acceleration at the neck generated by the 
activity in the vocal folds. When no phonation is detected, the microphone signal is 
registered as background noise, and when phonation is detected the microphone signal is 
registered as voice. Data can be registered continuously for up to one week before it must 
be downloaded to a computer with the software VoxLog Connect (version 3.1.18).  
 
 
Figure 1. The portable voice accumulator VoxLog with accompanying neck collar.  
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2.2.2 Dysarthria assessment 
Dysarthria assessment (in Swedish: Dysartribedömning) is a standardized clinical tool for 
assessment of respiration, phonation, oral motor function, articulation, prosody and 
intelligibility. It uses a four-point rating scale ranging from 0 to 3 (0: normal function to 3: 
severe deviation or no function) for each item. The mean score of all the sub-scales is 
calculated in a compound rating of dysarthria severity (Hartelius, 2015). The Dysarthria 
assessment by Hartelius (2015) was used in study V. An earlier version of the Dysarthria 
assessment (in Swedish Dysartritestet) with a five-point scale was used in study I-IV 
(Hartelius & Svensson, 1990). 
 
2.2.3 Questionnaire on Acquired Speech Disorders 
The Questionnaire on Acquired Speech Disorders (QASD, in Swedish: Självsvarsformulär 
om Förvärvade Talstörningar, SOFT) is a self-report questionnaire with items covering the 
speaker’s subjective symptoms and experiences related to living with an acquired speech 
disorder. It includes three subscales; “my speech and language”, “speech and language in 
social interaction” and “personal and environmental factors”. It uses a four-point rating 
scale (0: definitely false to 3: definitely true) with a higher score representing more severe 
symptoms. QASD is a clinical tool developed in Sweden; its results have been shown to 
have a moderate-to-strong correlation with those of similar instruments that are more 
extensively used abroad (Hartelius et al., 2008; Hartelius, 2015). 
 
2.2.4 Voice Handicap Index 
The Voice Handicap Index (VHI, in Swedish: RöstHandikappIndex) is a self-report 
questionnaire containing 30 items, rated on a five-point scale (0: never to 4: always) 
covering three different dimensions of subjective voice symptoms. The sub-scales include 
physical, functional and emotional symptoms, each represented by ten items. A sub-score 
for each dimension is calculated in addition to the total score (0-120) (Ohlsson & Dotevall, 
2009; Jacobsen et al., 1997). 
 
2.2.5 Montreal Cognitive Assessment 
The Montreal Cognitive Assessment (MoCA) is a screening instrument for cognitive 
dysfunction. It consists of several tasks designed to assess different cognitive domains 
including attention and concentrations, executive functions, memory, language, 
visuoconstructional skills, conceptual thinking, calculations and orientation. The maximum 
score is 30 points and 26 points represents a cut-off level for mild cognitive impairment 
(MCI) (Dalrymple-Alford et al., 2010; Nasredine et al., 2005). 
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2.3 PROCEDURES 
Before participation, a standardized assessment protocol following clinical routine was 
administered to all participants in each of the five studies. This included the Swedish clinical 
dysarthria test, Dysarthria Assessment (Hartelius, 2015; Hartelius & Svensson, 1990) and the 
self-report questionnaire QASD which covers subjective symptoms and experiences related 
to living with an acquired speech disorder. All participants in study I and study V also rated 
their voice function with the Swedish version of VHI (Ohlsson & Dotevall, 2009). Figure 2 
shows all VoxLog registrations performed in daily life, with the exception of study IV, in 
which VoxLog registrations were performed during semi-structured conversations in a 
clinical setting. Participants were given detailed instructions on how to wear and handle the 
VoxLog before beginning participation. Extra care was taken to instruct the participants on 
how to position the VoxLog collar to ensure proper placement and the positioning was 
evaluated during each visit to the lab.  
 
Figure 2. Flow-chart of VoxLog registrations performed in daily life. Each box represents one week of 
monitoring of voice use in daily life. Periods when intervention was given are shown in dark blue.  
 
During all VoxLog registrations the participants were asked to note their activities during the 
day in a voice journal provided on paper in a binder. They were asked to write down the 
activities they had been performing during the day in general terms in boxes separated the 
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hours of the day. Especially if they had done anything out of the ordinary, for example 
participating in a large social gathering such as a dinner party or attending a concert. Voice 
data from time periods when activities had been performed that could be expected to not be 
representative of ordinary voice use was removed from the analysis, for example attending 
choir practice. 
 
2.3.1 Study I 
This study included long-term registration of voice use in uncontrolled settings in daily life as 
well as in a controlled studio recording setting. Participants in both groups, PD and control, 
wore the VoxLog during eight days during their daily activities. During the eight-day study 
period, the participants visited the research clinic three times; the first start-up visit, one 
control visit after three to five days, and a final visit after which participation ended. Voice 
use during a monologue speech task in a controlled studio recording environment was 
registered with the VoxLog on each visit to the clinic. 
 
2.3.2 Study II 
The participant with PD was treated with LSVT LOUD® for four weeks, which included a 
total of sixteen individual hour-long treatment sessions. Voice use was registered in daily life 
with the portable voice accumulator VoxLog, for a total of nine weeks during the 
participation period for the participant with PD. This included one baseline week prior to the 
start of LSVT LOUD®, four weeks during LSVT LOUD® and one week directly after 
finishing treatment, resulting in six continuous weeks of voice use registration. Week-long 
follow-up registrations were also performed at three, six- and twelve-months post LSVT 
LOUD®. During the baseline registration, the participant visited a speech and language 
pathology clinic three times: first for enrollment and giving consent to participate, after three 
days to control proper registration with the VoxLog and after a week to end baseline 
registrations and start the treatment program. Registrations of monologue speech in a 
controlled environment in a recording studio were performed with the VoxLog at each of the 
three visits during baseline. During the post treatment registration week and the three follow-
up weeks (at three, six- and twelve-months post treatment), two clinic visits were performed 
to start and end registration of daily voice use and studio recordings were repeated at each 
visit following the same procedure as during baseline. The control participant performed the 
same long-term registration of voice use in daily life and controlled registrations in a 
recording studio during the baseline and follow-up week.  
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2.3.3 Study III 
The participants in study III underwent a week-long intervention with biofeedback 
administered with the VoxLog. Voice use was registered for a total of three consecutive 
weeks, one baseline week, one intervention week and one follow-up week. Registration with 
the VoxLog of monologue speech in a controlled studio environment was performed once 
during the baseline week and once during follow-up. The threshold level for the biofeedback 
was individually configured based on the voice use registered during the baseline week. 
During the intervention week the participants wore the VoxLog during the whole day with 
biofeedback activated. The feedback signal was activated when the voice sound level went 
below the set threshold level.  
 
2.3.4 Study IV 
The aim of study IV was to assess how the VoxLog biofeedback function should be 
configured to provide a low-frequency feedback closest to twenty percent. Six different 
biofeedback configurations were assessed, based on the configurable parameters in the 
software VoxLog Connect. Two different activation time settings were used: 500 ms and 
1000 ms, as well as three different threshold levels: 3, 6 and 9 dB SPL below the individual’s 
mean voice sound level in habitual speech during baseline registrations. Baseline registration 
with the VoxLog of habitual voice use were performed for each participant during a 10-15 
minute semistructured conversation together with the author (J.K.G.). Topics were prepared 
in advance and were chosen to encourage free discussion without too strong emotions; as 
sadness or anger, for instance, can be expected to impact the voice sound level used during 
conversation. Examples of topics were leisure activities, hobbies, work and travel 
experiences. After the baseline registration, six new semi-structured conversations with the 
different biofeedback configurations activated were performed. The biofeedback 
configurations were used in a randomized order between the different participants.  
 
2.3.5 Study V 
Study V was an intervention study in which the participants received biofeedback treatment 
with the VoxLog for four weeks. The biofeedback settings were individually adjusted based 
on the procedure recommended in study IV (Gustafsson, Södersten, Ternström & Schalling, 
2016); settings used were a threshold level 3 dB below the voice sound level during baseline 
and an activation time of 500 ms. Voice use was registered for a total of seven weeks. Six 
consecutive weeks including one week of baseline registration, four intervention weeks 
where biofeedback was administered, and one week after intervention. Voice use was also 
registered during a follow-up week three months after the treatment period. The assessment 
and voice registration followed the same procedure as in study II where the treatment effect 
on habitual voice use in daily life was assessed during and following LSVT LOUD®. The 
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participants visited the speech and language pathology clinic three times during the baseline 
week for dysarthria assessment and three registrations of monologue speech in a controlled 
environment in a recording studio. Weekly control visits were performed during the four 
intervention weeks where the biofeedback settings were updated if the participant had 
changed their voice use in comparison to baseline. Registrations of voice use in a controlled 
environment following the same procedure as during baseline were performed at the 
beginning and end of the post intervention and three-month follow-up period as well.  
 
2.4 ANALYSIS 
2.4.1 VoxLog registrations 
Data from the VoxLog registrations were downloaded to a computer using the accompanying 
software VoxLog Connect for all studies except study II (firmware 3.1.5 for study III, 
firmware 3.1.8 for study IV and 3.1.18 in study I & V). Using VoxLog Connect, the data can 
be visually presented in three graphs, showing phonation frequency, voice and noise sound 
level and phonation ratio for each registration day. The graphs of all registrations were 
visually inspected to identify if there were any incorrect registrations. These could be a result 
from malfunctioning electronics in the collar, a disconnected cable or that the participant 
forgot to power down the device when taking it off. The VoxLog Connect software can 
calculate mean values for the registration of voice sound level and noise sound level which 
was used for all studies. A different VoxLog software called VoxLog Discovery (firmware 
1.0.14) was used for study II. VoxLog Discovery is an updated software with a more user-
friendly interface but the older VoxLog Connect software was used in the subsequent studies 
as it allows for an easier process when backing up data. Data from a total of 127 weeks of 
continuous registration of voice use was collected in the studies that included field 
registrations; study I-III and V.  
Further analysis was made of the data from the field registrations in study I and V, with the 
help of a custom Matlab script which calculated mean voice sound level, noise sound level 
and phonation ratio in three different noise ranges. The noise ranges used were based on the 
Swedish Work Environment Agency’s recommendations concerning communication in noise 
(Arlinger, 1999) and can be seen in table 4. The custom Matlab script used also calculated 
self-to-other ratio (SOR) for the different noise ranges (Granqvist, 2003; Ternström, 1999;). 
Here, the SOR was defined as the difference between the uncompensated voice sound level 
and the noise sound level for the same time frame, as previously described by Szabo Portela, 
Granqvist, Ternström & Södersten (2018).  
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Table 4. Noise ranges  
Noise range dB range 
Low levels of environmental noise < 55 dB SPL 
Normal levels of environmental noise 55 – 70 dB SPL 
High levels of environmental noise > 70 dB SPL 
 
2.4.2 Statistical analysis 
The statistical analysis in all studies was performed with IBM SPSS Statistics for Windows 
(IBM Corporation, Armonk, NY). Version 21 was used for study III and IV, version 23 for 
study II and version 25 for study I and V.  
 
2.4.2.1 Study I 
Repeated measures ANOVA was used to assess differences on a group level. The analyses 
included voice sound level and noise sound level for the whole week-long registration period 
as well as voice sound level, SOR and phonation ratio in different levels of environmental 
noise. Paired t-tests with a Bonferroni correction were used to study differences between the 
groups for the individual parameters.  
 
2.4.2.2 Study II 
Comparisons of voice sound level and noise sound level for the participant with PD and the 
control was made for the whole week-long registration periods and also separated into work 
and leisure time. Voice use was also studied in the different noise ranges described in table 5; 
however, this analysis was made by exporting the data from VoxLog Discovery to a 
spreadsheet program (Microsoft Excel), rather than by the automated Matlab script that was 
used for study I and V. The voice sound level and noise level were also split into thirty-
minute segments and their correlation was calculated to assess the participant’s ability to 
regulate voice sound level following variations in noise sound level. The correlation 
coefficients were also calculated for the week-long registration periods to assess whether 
variations in voice sound level following the intervention covaried with the variations in 
noise sound level. Spearman’s rank correlation was used as some variables did not meet the 
assumption of normality, which was assessed using the Shapiro-Wilks test of normality.  
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2.4.2.3 Study III 
Comparisons of voice use before, during and after intervention were made for the week-long 
periods, in both individuals and groups, for the parameters voice sound level, noise sound 
level and phonation time, using the paired samples t-test. The results regarding voice sound 
level were also separated by percentage phonated above or below the individually set 
threshold level for the different registration periods. Mean results for the monologue speech 
task during registrations in a controlled setting in a recording studio was presented for the 
registrations made before and after intervention.  
 
2.4.2.4 Study IV 
To assess the feedback frequency acquired from six different biofeedback settings, the data 
was exported from VoxLog Connect to Matlab (version R2012b). A custom Matlab script 
was then used to identify the number of biofeedback activations and the number of speech 
utterances. The quotient of the two gives the feedback frequency. A speech utterance was 
defined as a phonated time segment of >500 milliseconds followed by a silent period of >500 
milliseconds. The participants naturally varied the voice sound level to some extent during 
the hour-long conversation, during which the different biofeedback settings were tested. As 
the threshold levels were based on the voice sound level used during the baseline registration, 
a correction quotient was calculated to achieve a corrected feedback frequency. The 
correction formula used was (actual threshold level/predetermined threshold level) x 
acquired feedback frequency.  
 
2.4.2.5 Study V 
Voice sound level and noise level were registered with the Voxlog for each of the seven 
weeks during participation; 1 baseline week, 4 intervention weeks, 1-week post intervention 
and 1 week at the three-month follow-up. Repeated measures ANOVA was used to assess 
differences in voice sound level and sound level on a group level over time. SOR was also 
studied in low, normal and high levels of noise. Linear regression analysis was performed to 
assess whether the changes in voice sound level after intervention could be interpreted as a 
result of the intervention or followed the variation in noise level. Regression analysis was 
also used to assess what effect screening results of cognitive function tested with MoCA had 
on the outcome in the difference in SOR after intervention. 
 
2.5 ETHICAL CONSIDERATIONS 
This project included recruitment of human participants which always involves challenging 
ethical considerations. One of the more unique aspects of this project is that the participants 
are asked to wear a portable voice accumulator, i.e. a device that registers voice use during 
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their daily activities outside the clinic for long periods of time. The VoxLog continuously 
registers the different voice parameters only; it never records the actual speech signal. This 
means that it is not possible to interpret or listen to what has been said during the 
registration period. This is very important for protecting the integrity of the participants and 
their conversational partners. It is however possible that wearing the visible device could 
lead to uneasiness for the participant. The participants were informed that they were 
allowed to end their participation at any time, without the need to give an explanation.  
 
This brings up another important ethical consideration regarding recruitment of 
participants. The participants with PD were recruited through their clinical contact and were 
invited to participate in ongoing studies by their regular SLP clinician. Great care was taken 
to inform the participants that their regular clinical contact would not be affected by their 
decision to participate or not, or to end their participation if they felt that fulfilling the study 
tasks was not feasible. No participants received any financial compensation. The potential 
benefit from participating in the studies was mainly an opportunity to receive information 
and learn more about their individual voice function and voice use.  
To ensure reliability and reproducibility, research is commonly performed in strictly 
controlled and defined environments, which also makes it easier to predict any 
complications or risks that could arise for the participant. In these studies, the participants 
were asked to wear research equipment in their daily life, inherently making complications 
harder to anticipate. To minimize risks when using the equipment, the participants were 
given very clear instructions on how to use and handle the device. For instance, participants 
were shown how to wear the VoxLog to minimize the risk of tangling up the cable 
connected to the collar. They were asked to wear the devices during as much time as 
possible during the day, and they were also carefully instructed to remove the device if they 
were going to perform activities where it would be unsafe to wear, e.g., during extraneous 
physical activity, showering, sleeping etc.  
Another important aspect linked to recruitment of participants is the fact that cognitive 
symptoms are common in Parkinson’s disease. Both the verbal and written information 
given within the project had therefore been carefully designed to be easy to understand and 
interpret, so that participants could make an informed decision regarding participation. 
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3 RESULTS 
3.1 VOICE USE IN PARKINSON’S DISEASE STUDIED WITH A PORTABLE 
VOICE ACCUMULATOR (STUDY I) 
3.1.1 Voice sound level and environmental noise during a week-long 
registration period in daily life compared to registrations in a 
controlled environment 
When comparing voice use in daily life between the individuals with Parkinson’s disease and 
matched healthy controls, a significant difference in voice sound level could be seen for both 
the male and the female groups. The male individuals with PD used a mean voice sound level 
6.1 dB lower than the control group (p = 0.003) and the female individuals with PD used a 
mean voice sound level 8.1 dB lower than the control group (p = 0.001). There was a non-
significant difference in noise level for the male groups (p = 0.401). A significant difference 
in noise level was found for the female groups (p = 0.025), where the mean noise level was 
4 dB lower for the individuals with PD. The mean difference in voice sound level and noise 
level, diffvoice/noise for the individuals with PD was 13.9 dB for the male group and 15 dB for 
the female group. The mean diffvoice/noise for the healthy controls was 17 dB for the male 
group and 19.1 for the female group.  
The mean voice sound levels during monologue speech in a controlled studio environment 
and in habitual speech in daily life, in different noise ranges, can be seen in figure 3. A 
significant main effect between the control group and the individuals with PD could be seen 
for both the male participants (p = 0.001) and the female participants (p = 0.001). Both the 
control group and the individuals with PD consistently used a higher voice sound level in 
daily life compared to controlled studio recordings, even in low levels of environmental 
noise.   
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Figure 3. Average voice sound level (dB) during monologue speech during a studio registration and in different 
levels of environmental noise during long-term registration in daily life, for all participants, separated by group 
and sex (n male PD group = 11; n male control group = 11; n female PD group = 10; n female control group 
10.). Bars denote +/- standard deviation.  
 
3.1.2 Self-to-Other Ratio during a week-long registration period in daily life 
Figure 4 shows the SOR in different levels of environmental noise for all participants 
separated by gender and group. There was a significant main effect between the control group 
and the individuals with PD for both the male participants (p = 0.001) and the female 
participants (p = 0.001).  
 
 
Figure 4. Self-to-other ratio (SOR) in different levels of environmental noise during long-term registration in 
daily life for all participants divided by group and sex (n male PD group = 11; n male control group = 11; n 
female PD group = 10; n female control group 10.). Bars denote +/- standard deviation.  
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3.1.3 Phonation ratio during a week-long registration period in daily life 
Both male and female individuals with PD used their voice significantly less on a group level 
compared to matched controls. The male group with PD had a phonation ratio 50% lower 
than the control group (p = 0.001). The corresponding difference for the female group with 
PD was 60% less phonation ratio than the control group (p = 000.1). When studying the 
phonation ratio in different ranges of noise levels, a significant interaction effect could be 
seen (p = 0.031 for the male groups and p = 0.011 for the female groups); individuals with 
PD used their voice less in high noise levels, as can be seen in figure 5.  
 
 
Figure 5. Phonation ratio (percent) in different levels of environmental noise during long-term registration during 
daily life for all participants divided by group and sex (n male PD group = 11; n male control group = 11; n 
female PD group = 10; n female control group 10.). Bars denote +/- standard deviation.  
 
3.2 OUTCOME AFTER LSVT LOUD® STUDIED WITH A PORTABLE VOICE 
ACCUMULATOR (STUDY II) 
The individual with PD who underwent LSVT LOUD® intervention increased his mean 
voice sound level by 4.1 dB in the week after intervention, compared to the baseline week 
when measured with the VoxLog during daily voice use. During monologue speech in a 
controlled lab environment, the increase after intervention was 5.6 dB. The difference in 
voice sound level and noise level, diffvoice/noise was 20.2 dB during baseline and 24.2 dB in the 
week post intervention. At the three-month follow-up, the difference in voice sound level 
compared to baseline was 3.5 dB while diff voice/noise was 17.8 dB. The difference in voice 
sound level compared to baseline was 2.3 dB at the six-month follow-up, with a diff voice/noise 
of 18.5 dB. At the one-year follow up, the difference in voice sound level compared to 
baseline was 1.4 dB and the diff voice/noise was 20.4 dB.  
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Figure 6. Mean voice sound level and mean noise sound level during the whole week-long monitoring periods 
for both participants. The mouth-to-microphone distance was approximately 10 cm.  
 
To assess whether variations in noise level explained the variations in voice sound level, the 
correlation between voice sound level and noise level was calculated over all registration 
periods. No significant correlation was found for the individual with PD, Spearman’s rho = 
0.25 (p = 0.515). A significant correlation was however found for the control participant, 
Spearman’s rho = 0.94 (p = 0.005).  
Table 5. Correlations between the participants’ Lvoice and the Lnoise within respective registration period 
including pretreatment, post treatment and at follow-up (FU) three, six, and twelve months post treatment. 
Period Spearman’s rho p-value 
Individual with PD - Pre 0.53* 0.000 
Individual with PD - Post 0.28* 0.032 
Individual with PD - FU3 0.64* 0.000 
Individual with PD - FU6 0.60* 0.000 
Individual with PD - FU12 0.58* 0.001 
Control – Pre 0.83* 0.000 
Control – Post 0.79* 0.000 
*Significant correlation (p < 0.05).  
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Correlation was assessed also on 30-minute segments for the whole registration period, to 
study how well the participants regulated their voice sound level in response to variations in 
noise. Table 5 shows the correlation coefficients and p-values for all periods.  
 
3.3 BIOFEEDBACK DELIVERED WITH A PORTABLE VOICE ACCUMULATOR 
(STUDY III-V) 
3.3.1 Outcome after a single-week biofeedback intervention (Study III) 
A significant mean increase of 1.5 dB in voice sound level was seen during the intervention 
week compared to during the registrations the week before intervention (p < 0.05). The 
difference in mean voice sound level after the intervention week compared to baseline or 
compared to the intervention week was not significant. There was no significant difference in 
noise level between the different registration periods. The diffvoice/noise for the pre intervention 
week was 13.6 dB, 15.1 for the intervention week and 12.9 dB during the post intervention 
week.  
 
Figure 7. Box plots presenting voice sound level for the three registration weeks for the group of participants (n 
= 6). The line shows the median, the boxes the first and third quartile and the bars denote 95% confidence 
intervals. 
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Figure 8. Box plots presenting noise level for the three registration weeks for the group of participants (n = 6). 
The line shows the median, the boxes the first and third quartiles, and the bars denote 95% confidence intervals, 
outliers are shown with a separate circle. 
 
3.3.2 Methodological development (Study IV) 
The six different biofeedback settings (two different activation times; 500 and 1000 msec, 
and three different threshold levels; 3/6/9 dB below mean voice sound level) resulted in a 
feedback frequency range of 0 - 49.8%. Figure 9 show mean feedback frequency for each 
setting and the corresponding 95% confidence intervals. The feedback setting that resulted in 
a feedback frequency closest to 20% was a threshold level 3 dB below mean voice sound 
level and an activation time of 500 msec.  
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Figure 9. The figure shows 95% confidence intervals showing feedback frequency for the different feedback 
settings.  
 
3.3.3 Outcome after a four-week biofeedback intervention (Study V) 
A mean increase of 1.6 dB in voice sound level was seen the week post intervention 
compared to the week pre intervention for the group of 8 participants. The corresponding 
increase during the follow-up registration was 1 dB. Comparing voice sound level and noise 
sound level for each period, diffvoice/noise, the mean difference was 12.5 dB during the pre-
intervention registration period, 16.3 dB during the post intervention period and 16.5 dB 
during the follow-up period. The differences between the pre/post and pre/follow-up periods 
were significant (p > 0.05 in both cases).  
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Figure 10. Box plots presenting voice sound level for the seven registration weeks for the group of participants 
(n = 8). The line shows the median, the boxes the first and third quartile and the bars denote 95% confidence 
intervals.  
 
The changes in voice sound level over all periods could not be significantly predicted by the 
variations in noise level in a linear regression analysis (r2 = 0.068, p = 0.053).  
 
Figure 11. Box plots presenting noise level for the seven registration weeks for the group of participants (n = 8). 
The line shows the median, the boxes the first and third quartile and the bars denote 95% confidence intervals, 
outliers are shown with a separate circle. 
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The SOR in different noise ranges for the periods pre-intervention, post intervention and 
follow-up (box plots shown in figure 12) exhibited no significant differences between the 
different periods at the group level (p > 0.05 in all cases). However, a distinction could be 
seen between four individuals who scored above the cut-off for MCI on the cognitive 
screening with MoCA (>26 points) and four individuals who scored below the cut-off level 
(<26 points). The group who scored within normal levels saw a more positive treatment 
outcome with generally increased SOR during follow-up compared to pre-intervention, while 
the pattern was reversed for the group with MoCA scores below normal levels (individual 
values shown in figure 13 and 14). A linear regression analysis showed that MoCA scores 
significantly predicted SOR outcome with 92.4% explained variability in normal noise ranges 
(p = 0.001) and 87.6% explained variability in high noise ranges (p = 0.001).  
 
Figure 12. Box plots showing the Self-to-Other Ratio for the different noise ranges and the pre, post and follow-
up week for the group of participants (n = 8). The line shows the median, the boxes the first and third quartile 
and the bars denote 95% confidence intervals, outliers are shown with a separate circle.  
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Figure 13. Diagram showing the mean Self-to-Other Ratio in the different noise ranges for the four participants 
(Id 1, 2, 7, 8) with a MoCA score > 26 before intervention (Pre) and at three-month follow-up (FU). 
 
Figure 14. Diagram showing the mean Self-to-Other Ratio in the different noise ranges for the four participants 
(Id 3, 4, 5, 6) with a MoCA score < 26 before intervention (Pre) and at three-month follow-up (FU). 
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4 DISCUSSION 
In this thesis, the impact of PD on the individual’s ability to communicate has been explored 
using methods to study voice use in daily life. The portable voice accumulator VoxLog, used 
in all the studies included in the thesis, also has a biofeedback function that can be used for a 
therapeutic purpose. Further goals of the thesis have been to assess outcomes after traditional 
voice treatment for individuals with PD, LSVT LOUD®, and to test, develop and evaluate 
biofeedback intervention using the VoxLog. The studies included in this thesis are the first to 
objectively assess voice use in daily life in individuals with PD. How daily communication, 
voice function and voice use are affected by PD is of particular interest, since a discrepancy 
between voice use in controlled environments and in daily life could be expected to be high 
following the various motor and non-motor symptoms common in PD.  
 
4.1 WEARABLE TECHNOLOGY AND ECOLOGICAL VALIDITY 
The use of PVAs to study voice use in a setting closer to the speaker’s daily life dates as far 
back as the seventies, when Holbrook, Rolnick & Bailey (1974) used a portable device to 
monitor voice intensity for individuals with vocal fold lesions and hyperfunction. Despite the 
vast technological advancements made in the decades since then, there are still no portable or 
wearable devices commonly used in clinical practice related to voice disorders. When work 
started on this thesis project, there were mainly two portable voice accumulators 
commercially available; the VoxLog and the Ambulatory Phonation Monitor, developed both 
with research and clinical use in mind. A device specifically made for clinical use, the 
VocaLog, was soon introduced. The VoxLog is not commercially available at the present 
date, and a few new devices have been developed around the world, mainly with a research 
focus, such as the Voice Health Monitor (Mehta et al., 2015) and the Voice Care (Astolfi, 
2016a; Astolfi, 2016b). The use of wearable technology to study voice use does provide a 
method to fill in an important knowledge gap in voice research and therapy. Voice function is 
traditionally studied in controlled environments to ensure validity and replicability or through 
subjective ratings of voice use. Quantitative data on voice use in settings outside controlled 
clinical settings are lacking. The findings from study I showed significant differences in voice 
use between the group with PD and the healthy controls regarding voice sound level and 
phonation ratio in different noise ranges. Voice use is, as hypothesized, different in daily life 
compared to recordings in a controlled environment.  
 
4.2 CHANGES IN VOICE USE IN INDIVIDUALS WITH PD 
A wide variety of both objective and subjective changes in voice function, voice use and 
communication following PD have been described (Duffy, 2013; Baylor et al., 2011; Miller 
et al., 2006). One of the most prominent is of course a decreased voice sound level, leading to 
difficulties making oneself heard.  
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4.2.1 Changes in voice sound level following PD 
Voice use in daily life was examined for individuals with PD and matched healthy controls in 
study I. Significant differences in voice sound level were found between the groups, for both 
the male and female participants. The female group of individuals with PD used a mean voice 
sound level that was 8.1 dB lower than their matched healthy controls during one week of 
monitoring with the VoxLog in daily life. For the male group of individuals with PD, the 
mean voice sound level was 6.1 dB lower than the matched group of healthy controls. The 
difference in voice sound level between individuals with PD and healthy controls have been 
studied earlier by Fox and Ramig (1997), although in a controlled studio setting and not in 
daily life. In different speech tasks including sustained vowel phonation, reading and 
monologue speech during a controlled studio recording, individuals with PD had an average 
voice sound level that was 2-4 dB lower than the healthy controls (Fox & Ramig, 1997).  
The reduced voice sound level in PD can be explained as an effect of the hypokinesia and 
rigidity characteristic for PD. Hypokinesia, implying decreased amplitude of movements, and 
rigidity can be expected to impact both respiratory, laryngeal and articulatory movement 
leading to a reduced voice sound level (Baker, Ramig, Luschei & Smith, 1998; Duffy, 2013; 
Fox et al., 2002; Luschei, Ramig, Baker & Smith, 1999; Pfann, Buchman, Cornella & 
Corcos, 2001). The non-motor symptoms related to PD could however be a strong 
contributing factor as well. Changes in central sensory processing have been reported to 
create difficulties for self-regulating the voice sound level in response to internal cues, and to 
decrease awareness of the speakers own soft voice (Arnold, Gehrig, Gispert, Seifried & Kell, 
2014; Clark, Adamas, Dykstra, Moodie & Jog, 2014; Guehl et al., 2008; Ho et al., 2000; 
Houde et al., 2004; Kwan & Whitehill, 2011; Mollaei, Schiller & Gracco, 2013; Liu, Wang, 
Metman & Larson, 2012; Sapir et al., 2014). The increased difference in voice sound level 
between individuals with PD and healthy controls seen in study I and study II compared to 
earlier reports by Fox and Ramig (1997) might be a result of this as well. Unlike the studio, 
there are in daily lifemany distractors that increase the cognitive load, leaving less energy and 
focus for speech production. These factors include variations in noise, stress, physical 
movement and emotional state, and possibly others. An example of a clinical representation 
of this, familiar to many with experience of working with patients with PD, is to observe the 
patient walking from a clinic waiting room to the clinician’s office. The patient’s voice sound 
level is often stronger during the greeting in the waiting room, which is short and concise, 
and while sitting down in the clinician’s office, where the noise is reduced and no physical 
movement is involved, compared to during the walk to and from the office where noise, 
movement and postural balance increases the cognitive load. In many cases, conscious or 
unconscious compensatory strategies are used, such as keeping silent or refraining from 
talking.  
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4.2.2 Impact of environmental noise on voice sound level 
Variations in noise level are known to lead to a somewhat unconscious regulation of voice 
sound level (Lombard, 1911). This phenomenon has also been studied in individuals with PD 
and it has been shown that individuals with PD react to variations in noise level in a pattern 
similar to that in healthy speakers on a group level (Adams & Lang, 1992; Dromey & 
Adams, 2000;  Ho, Bradshaw, Ianseck & Alfredson, 1999; Sadagopan & Huber, 2007; 
Stathopoulos et al., 2014). The findings in study I and II confirm these earlier results, 
according to which increasing noise levels leads to increasing voice sound levels during 
speech in daily life. Even though based on only one pair of participants, there was a 
difference between the individual with PD and the matched control in study II such that the 
correlation between variations in noise level and regulation of voice sound level was stronger 
for the control participant during the registration period before intervention started; 
Spearman’s rho = 0.81 for the control and Spearman’s rho = 0.53 for the individual with PD. 
In this single pair of participants both of them regulated their voice sound level in response to 
changes in noise level, but the healthy speaker did so to a greater extent.  
 
4.2.3 Changes in phonation ratio following PD 
Limitations in communicative participation are commonly reported by individuals with PD 
(Baylor et al., 2011; Miller et al., 2006). The results from study I show that the matched 
healthy controls used their voice 50-60% more than the individuals with PD on a group level. 
The phonation ratio represents the percentage time spent phonating during the registration 
period. It might be used to quantify objectively the communicative participation, which 
inherently is something quite subjective. It is difficult to know whether the lower phonation 
ratio is a result of the individuals with PD taking a less active role in communication, or if the 
difference is related to individuals with PD being less communicative situations because of 
the physical impairments making it more challenging to take part in social gatherings 
altogether; as reported by Sjödal Hammarlund, Westergren, Åström, Edberg & Hagell 
(2017). An interesting finding in study I on this topic is that an interaction effect was found, 
showing that individuals with PD do not increase their phonation ratio in situations with high 
environmental noise, which was the case for the control groups. A situation or environment 
with high noise levels is in many cases a social situation, for example a restaurant, café or 
dinner party, where communication naturally occurs more frequently. This would explain 
why the phonation ratio increased in high noise ranges for the control groups. That a similar 
pattern was not seen for individuals with PD could suggest that they were not as active in 
such situations as their healthy controls.  
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4.3 INTERVENTION AND HYPOPHONIA RELATED TO PD 
The changes in central sensory processing and internal cueing deficits  in PD may be one 
contributing factor to why the hypokinetic dysarthria common in PD generally does not 
respond to pharmaceutical or surgical intervention methods that primarily target the 
dopamine deficiency (D’Alatri et al., 2008; Ho et al., 2008; Pinto et al., 2005; Plowman-Prine 
et al., 2009; Ramig et al., 2007; Schulz et al., 2012; Skodda et al., 2010; Skodda et al., 2012). 
The limited and variable effect on speech and voice symptoms from pharmaceutical and 
surgical treatment have made behavioral approaches the main treatment option for dysarthria 
and hypophonia in PD. Study II aimed to examine the outcome from the leading voice 
therapy option, LSVT LOUD®, through assessing changes in voice use in daily life with the 
help of the PVA VoxLog. Initially planned as group trial, it was later revised to a pseudo-
single case study with a matched healthy control to better fit the scope of the present thesis 
project.  
In study II, a 4.1 dB increase in voice sound level averaged over one week was seen for the 
individual with PD after LSVT LOUD® intervention, compared to the baseline week voice 
sound level. For monologue speech during a controlled studio recording the corresponding 
increase after intervention was +5.6 dB. This increase was comparable to previously reported 
outcomes in a similar context: mean +4.7 dB by Ramig et al. (2001) and mean +5.2 dB by 
Ramig et al. (2018). A greater improvement during a defined speech task during a controlled 
recording (5.6 dB increase) compared to field recording (4.1 dB increase) was expected as 
there are fewer distractors competing with the focus on speech production. A gradual decline 
in the retained treatment effect on voice sound level was seen during the follow-up periods as 
follows: directly post intervention: 4.1 dB above baseline, three-month follow-up: 3.5 dB, 
six-month follow-up: 2.3 dB, twelve-month follow-up: 1.4 dB. The change in voice sound 
level during monologue speech during registration in a studio environment at twelve-month 
follow-up was 3.8 dB compared to baseline in study II. In the study by Ramig et al. (2018) 
follow-up was made at seven months and the mean difference in voice sound level during 
monologue speech was 2.8 dB. Ramig et al. (2001) performed follow-up recordings of 
monologue speech after 24 months and the difference in voice sound level compared to 
baseline was 2.3 dB. The decay of treatment effect, or disease progression, follows a similar 
pattern in all studies, both during controlled recordings and during voice use in daily life.  
 
4.4 BIOFEEDBACK INTERVENTION FOR HYPOPHONIA RELATED TO PD 
The clinical experience of some individuals with PD showing positive outcome with 
increased voice sound levels during speech tasks in a controlled environment after voice 
treatment, yet still struggling with the transfer to voice use in daily life gave the impetus to 
this thesis work. Being able to provide real-time biofeedback regarding voice sound level in 
daily life is promising for individuals with PD, since the training happens in the context 
where change and improved voice function are desired. And, considering the deficiencies in 
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internal queuing previously described, providing an external que through the biofeedback 
should promote a new motor behavior for the group. The use of external biofeedback has 
been shown earlier to have positive results for individuals with PD albeit in a controlled 
practice setting (Laukkanen et al., 2004; Le Dorze et al., 1992; Norrlinder & Olsson, 2009; 
Sadagopan & Huber, 2007; Schneider-Stickler et al., 2012; Scott & Caird, 1983). 
 
The aim of study III was therefore to evaluate the effects of a one-week intervention where 
individuals with PD received continuous biofeedback of voice sound level in daily life. The 
hypothesis was that receiving continuous feedback on the target behviour (habitual speech in 
daily life) with the help of external biofeedback should promote generalizability. An increase 
in voice sound level (1.5 dB) and diffvoice/noise (1.4 dB) was seen during the intervention 
compared to baseline but the effect was not retained when the biofeedback period stopped 
(increased voice sound level of 1.3 dB but a decreased diffvoice/noise of -0.7 dB). The 
participants reported that using the device helped them become more aware of how they were 
using their voice and, in some cases, inquired about the possibility to use the device as a 
technical aid. This led to the planning of study IV in which the biofeedback configuration 
was experimentally tested to find settings likely to promote retention of learned behavior 
based on principles of motor learning. The results from study IV where then used in study V 
in which an extended biofeedback intervention was evaluated. A four-week long intervention 
period was used to match the intensity of practice that LSVT LOUD® offers.  
The results from study V showed a mean increase in voice sound level of 1.6 dB the week 
after intervention compared to the week before intervention. The corresponding difference at 
three-month follow-up was 1 dB. When taking variations in noise level into account the 
diffvoice/noise was 3.8 dB after intervention compared to before. At the three-month follow-up 
the difference was 3 dB. Comparing the results with the one-week biofeedback intervention 
the four-week intervention had a more successful outcome, indicating that a longer, more 
intensive, practice period was needed to achieve retention of the improved skill. In study II, in 
which the participant with PD underwent LSVT LOUD®, a greater increase in voice sound 
level of 4.1 dB in daily life was seen during the week post intervention together with a 
comparable increase in diffvoice/noise of 4 dB. At the three-month follow-up the outcome seen 
in study II was a 3.5 dB increase in voice sound level, but a -2.4 dB decrease in diffvoice/noise,as 
compared to the baseline. In study V, at the three-month follow-up the increase in voice 
sound level was 1 dB but an increased diffvoice/noise of 3 dB was seen on a group level. This 
could be interpreted as a more positive outcome following the four-week biofeedback 
regarding the ability to make oneself heard above the noise level. However, the diffvoice/noise at 
three-month follow-up was 16.5 dB and 17.8 dB respectively. Arlinger (1999) proposed that 
a diffvoice/noise of 15 dB is needed to easily be heard above the noise level. With that in mind, a 
further increased diffvoice/noise might not have been needed for the individual with PD in study 
II.  
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4.5 MOTOR LEARNING AND PD IN RELATION TO BIOFEEDBACK 
INTERVENTION 
The basal ganglia, where the dopaminergic deficiency resulting in PD originates, have been 
shown to play a critical role in motor learning (Brasted & Wise, 2004; Graybiel, 1995; 
Graybiel, 2005). There were early suggestions that individuals with PD might be resistant 
to behavioral treatment (Weiner & Singer, 1989) and that the capacity for motor learning 
and generalization have been impaired (Agostino et al., 2004; Schulz et al., 2000). These 
notions have been challenged in recent years (Niewboer et al., 2009; Pendt et al., 2011; 
Petzinger et al., 2013), not least in view of the positive outcomes after intervention for 
example shown in studies of LSVT LOUD® (Ramig et al., 2001; Ramig et al., 2018).  
Providing real-time, continuous biofeedback on voice sound level in daily life could in 
many ways be motivated as the ideal way to promote a change in motor behavior for 
individuals with PD. A majority of those principles of motor learning that have been shown 
to facilitate retention of an improved motor skill after training (described in table 3) are 
achieved when biofeedback is delivered by a PVA that is monitoring the individuals’ 
habitual speech during their daily activities. The feedback provided through the VoxLog 
can be configured to provide a low-frequency feedback and it comes in the form of 
knowledge of results as the vibration is triggered only if the voice sound level goes below 
the set threshold level. Depending on the training period, the practice can be distributed 
over time and a high number of trials can be achieved. The speech target is habitual speech 
in daily life which inherently provides a randomized practice as new and ever-changing 
utterances are produced in communication and the practice becomes varied as different 
contexts are offered continually. With the settings that are configurable in the VoxLog 
practice cannot be presented in a delayed manner; the feedback can be provided only 
immediately. In summary, all principles of motor learning promoting retention except one 
can be achieved when trying to promote lasting change in motor skill through training with 
biofeedback provided by the VoxLog.  
An additional benefit of providing real-time biofeedback on habitual voice use in daily life 
is that the deficits in central sensory processing and internal cueing can be addressed with 
this method (Arnold et al., 2014; Clark et al., 2014; Guehl et al., 2008; Ho et al., 2000; Houde 
et al., 2004; Kwan et al., 2011; Liu et al., 2012; Mollaei et al, 2013; Sapir et al., 2014). The 
biofeedback signal provides an external cue that could help the individual with PD regulate 
the voice sound level more efficiently than when relying solely on internal cues.  
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4.6 COGNITIVE FUNCTION AND BEHAVIORAL TREATMENT IN PD 
The results from study V showed that individuals who scored at or above the cut-off level for 
MCI on the cognitive screening tool MoCA had a better outcome after biofeedback 
intervention than the group who scored below the cut-off level for MCI. The lack of lasting 
results for the group with lower MoCA scores could be a consequence of difficulties in 
managing the technical aspects of using the VoxLog and how to respond to its biofeedback 
signal, or perhaps of increased difficulties using internal cues to regulate voice sound level 
after the biofeedback was removed. Attention deficits related to PD could affect also the 
ability to notice and respond to the biofeedback signal (Dujardin et al., 2013). Many of the 
participants who did not complete the whole participation period in study V reported that 
managing the device was cumbersome, leading to the interpretation that this could have been 
the case for those with lower MoCA scores who completed the participation in full as well. 
Screening of cognitive function is be recommended in future studies that employ technical 
aids such as a PVA to provide biofeedback for individuals with PD.  
 
4.7 METHODOLOGICAL DISCUSSION 
All participants with PD where consecutively recruited to participate in the studies through 
the participants own initiative after receiving information through their clinical contact or 
local patient organizations. In many cases there will be a certain type of individual who 
shows interest in participating in studies that involves active participation. One can expect 
such individuals to be more active and be in an earlier stage of the disease progression as it 
demands energy and commitment to participate. This can be seen to a large extent in the 
participant characteristics in the different studies. A majority were rated to have a mild 
hypokinetic dysarthria and only a few showed moderate dysarthria during the assessment. 
This can however partly be explained by the fact that the Swedish clinical dysarthria 
assessment protocol (Hartelius, 2015; Hartelius & Svensson, 1990) includes tasks to capture 
all different sub-types of dysarthria. A hypokinetic dysarthria often leads to a low score even 
when moderate in its severity. No information on general disease severity was gathered for 
the participants with PD as a result of the participants having neurologist contacts at different 
clinics and it is not part of clinical practice everywhere to regularly and explicitly report for 
example Hoehn & Yahr staging scale (Hoehn and Yahr, 1967) ratings in the patient record.  
 
4.7.1 Working with the VoxLog 
The VoxLog was chosen for this thesis project as it is the only PVA that offers the ability to 
monitor noise level in addition to voice sound level, phonation ratio and fundamental 
frequency. The main voice parameter of interest for individuals with PD is the voice sound 
level, given that a decreased loudness is one of the most common symptoms in PD. As 
variations in noise level are expected to impact a speaker’s voice sound level (Lombard, 
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1911), the ability to control for changes in noise level when studying voice sound level made 
the VoxLog the obvious choice of PVA for this project. 
The microphone used in the VoxLog collar to register sound pressure level comes factory 
calibrated, eliminating the need for daily calibration as with for example the APM. The APM 
needs to be calibrated before each use as the voice sound level registered is estimated based 
on the activity in the accelerometer glued to the wearers throat. Variations in the calibration 
period can then introduce errors as different calibrations can impact the estimation of voice 
sound level. This is not a risk using the VoxLog with its combined accelerometer and 
microphone approach to voice registration. The fact that the accelerometer and microphone in 
the VoxLog are worn in a collar that is fitted around the neck, instead of an accelerometer 
glued to the neck, as with the APM, but this introduces another potential risk of measurement 
error. The microphone is situated at the neck approximately 10 cm from the mouth. The most 
common head position during conversation is with a somewhat neutral position facing 
straight ahead and small variations can be expected to not impact the values to a large extent. 
But during long periods of registration there will of course be many occasions where the 
wearer has spoken with her head turned or tilted which can alter the mouth-to-microphone 
distance. This is a source of error that must be taken into account when studying results from 
VoxLog registrations. It can however be expected that this variation to some extent would 
average outover a week-long registration period; one would expect situations both with a 
decreased and an increased mouth-to-microphone distance to occur during daily activities. 
Careful instructions were also given to all participants to always position the collar the same 
way each day to minimize the risk of varying mouth-to-microphone distances. 
The mouth-to-microphone distance that results from the position of the VoxLog collar has to 
be taken into account when making comparisons of results to the more common 30 cm 
mouth-to-microphone distance. Voice sound level values can therefore seem quite high at a 
first glance. The data registered with the VoxLog is approximately 7.2 dB higher compared to 
a mouth-to-microphone distance of 30 cm (Wirebrand, 2012). Results have generally been 
shown in their original state in the studies in this thesis project to minimize the use of this 
approximation with the exception of study I. The approximation was used in study I to allow 
for an easier comparison with other studies as the aim of the study was to increase the 
knowledge of how PD impacts voice use, and not to experimentally assess the outcome of an 
intervention for example, as in study II, III and V.  
Using the VoxLog has also introduced many technical challenges, especially broken devices 
and collars. This problem that was somewhat alleviated when Sonvox AB updated the design 
of the collars to a sturdier model. A recurring problem was also the cable between the 
VoxLog device and collar that tended to disconnect, leading to a loose or completely cut-off 
connection, often without the wearer noticing it immediately. These situations were 
intercepted, as all data was visually inspected for faulty registrations which were then 
removed from the analysis. It is however impossible to be sure that all errors were big or long 
enough to be clearly visible. Some smaller errors were probably missed and therefore stayed 
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forthe analysis. Registering voice use in daily life over long periods of time also leads to large 
amounts of data to process, all in all, data from 127 weeks of field registrations were analyzed 
in this project. With one data point being created for each 5 second time frame the resulting 
data set can be challenging to handle. The participants were asked to fill out a voice journal 
on paper during each day, intended to be used as a guide when analyzing the data. Initially, 
the goal was to use the voice journal to allow for more detailed analysis of voice use based on 
activity or perhaps different discreet communicative situations (number of participants during 
a conversation for example). Using a voice journal with handwritten notes is however not 
easy for individuals with PD, since micrographia and trouble writing by hand are common 
due to tremor and hypokinesia. Furthermore, not all participants remembered filling in the 
journal continuously during the whole registration period, so some data were missing in a few 
cases. The voice journal was therefore used to identify periods of voice use not representative 
of normal voice use. For example, one participant in study I attended choir practice and 
registrations during those periods were removed from the analysis as choir singing was 
interpreted as not representative of conversational speech. An automatic sound scene 
classifier, as describe in a PhD thesis by Peter Nordqvist (2004), or a digital voice journal, for 
example in the form of an app for a smartphone, could be a more feasible option to gather 
information in voice use for this population. Pre-defined choices could improve increased 
usability for the participants and make the grouping of activities easier during analysis. Such 
an app could also provide automated reminders to report into the voice journal, thus 
decreasing the risk for missing data.  
 
4.7.2 The biofeedback capabilities of the VoxLog 
When using the VoxLog’s biofeedback function, there are some options that can be adjusted 
in the settings. These are the threshold level, at which voice sound level value the 
biofeedback will trigger if it goes above or below (for example 72 dB, can be set with a 
numerical number); the activation time, for what amount of time should the threshold level be 
passed before the biofeedback is triggered (for example 500 msec, can be set to 
predetermined values; 1 sec, 500 msec, 200 msec and 100 msec); rest time, amount of time 
after a biofeedback activation that the biofeedback is deactivated so that it does not repeat the 
signal immediately (for example 10 seconds, can be set with a number). Signal time; length of 
the biofeedback activation (for example 1 second of vibration, can be set with a numerical 
number).  
Changing the threshold level and the activation time will allow the most amount of control 
over how often the biofeedback will activate, i.e., the feedback frequency. This was used in 
study IV to test systematically what the resulting feedback frequency would be from six 
different predetermined settings. Even with these configurable settings, the ability to control 
the feedback manually is somewhat limited. The feedback can be delivered only in a direct 
manner, and not delayed, although the latter has have been found to promote retention in 
motor learning (Bislick et al., 2012; Maas et al., 2008). Neither can the device provide 
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summary feedback, used for example by Adams et al. (2002), where feedback from multiple 
trials is summarized after a period of time. The feedback settings are rigid and can be 
adjusted only when connecting the device to a computer with the accompanying software. 
Learners of different skill levels are helped by feedback in different ways, depending on 
where they are in their learning process (Guadagnoli & Lee, 2004). A more sophisticated 
feedback regime could provide direct feedback initially with a high-frequency, to help with 
acquisition of the skill and promote behavior change, and then adjust to a delayed, low-
frequency feedback as training progresses. Such a modular approach could provide a more 
effective feedback schedule to help improve and consolidate a new skill. 
There is also the question of whether a threshold level focusing on voice sound level is the 
most useful approach. The voice sound level required to make oneself heard in conversation 
depends on the level of the ambient noise. An adaptive biofeedback function with a threshold 
based on SOR instead of the voice sound level could be a more ecologically valid approach. 
The threshold level would then be adaptive based on noise level in the previous time frames 
during the continuous registration performed by the PVA, instead of a fixed threshold level as 
in for example the VoxLog.  
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5 CONCLUSIONS 
Individuals with PD exhibit objectively measured limitations in communicative participation 
when studied in the form of phonation ratio. Individuals with PD used their voice 50-60% 
less, compared to matched healthy controls, during a week-long period of monitoring of 
voice use in daily life. 
Monitoring voice use with a PVA can be a valuable complement to traditional voice 
assessment, because voice sound levels used during studio recordings in a controlled 
environment are not representative of voice sound levels used during monitoring in daily life, 
neither for individuals with PD nor for healthy controls.  
Although limited in scope, the evaluation of treatment outcome regarding changes in voice 
sound level in daily life following LSVT LOUD® shows that changes previously reported 
during controlled recordings in a studio setting are reflected also in daily life.  
When using a PVA for biofeedback purposes, the biofeedback should be carefully configured 
based on the individual’s voice use during a baseline registration period. With the current 
capabilities of the VoxLog, a biofeedback threshold 3 dB below mean voice sound level and 
an activation time of 500 msec is recommended when the aim is to achieve a low-frequency 
feedback. 
Results from this thesis indicates that providing continuous biofeedback regarding voice 
sound level in daily life with a PVA can help individuals with PD increase their voice sound 
level in relation to noise level, and thus to make themselves heard more easily.  
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6 CLINICAL IMPLICATIONS 
Assessment of voice use and function in PD should include methods to study voice activity in 
a more ecologically valid and less controlled setting. This could be a valuable complement to 
the more controlled methods used today to further understand the challenges faced in daily 
life by patients with voice disorders. Objective information about voice use in daily life is 
also important when studying transfer and retention of skills acquired during voice treatment. 
Providing direct biofeedback on voice use in daily life could be a valuable complement to 
traditional treatment of hypophonia in PD offered in a clinical setting, either as a method to 
help improve transfer and generalization of improved voice function following therapy, or as 
an option if traditional voice therapy such as for example LSVT LOUD® is not suitable for 
the individual. This could be applicable for younger individuals with PD who are still 
working and where it can be challenging to comply with a treatment period that entails 
sixteen visits to a voice clinic during a four-week period, or individuals with PD who might 
not have the energy to perform that many trips outside the home during such a short period of 
time. Promoting self-led training and exercise in the home can also empower the patient. The 
cost for the healthcare system is significantly reduced with fewer visits to the clinic. Reduced 
cognitive function may be a factor limiting possibilities to gain from biofeedback on voice 
sound level and should therefore be tested before including participants.  
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7 FUTURE DIRECTIONS 
The use of portable voice accumulators to monitor voice use should preferably be 
accompanied by a voice journal to allow for a more detailed analysis and understanding of 
the material. An integrated, user-friendly, app could meet these needs, and also prompt the 
user to fill out the information regularly.  
Further larger scale research is needed to determine the efficacy of using biofeedback 
regarding voice sound level to help treat hypophonia related to PD. Development of the 
capability to administer different biofeedback programs based on the user’s skill level and 
progression during the training is needed to make the method more robust. An adaptable and 
modular feedback function that regulates the voice threshold level based on noise sound level 
during the speech and progressively increases the challenge for a more skilled individual 
would create ideal conditions to promote change.  
In this project, the effects of biofeedback as a singular intervention method has been studied. 
It could be the case that biofeedback would be more effective as a complement to help 
patients with transfer and generalization after more traditional voice therapy. It would 
therefore be of great interest to see if the retention of treatment effects after LSVT LOUD®, 
for example, is increased by adding a period of biofeedback regarding voice sound level after 
the treatment period. The combination of both methods might be the ideal approach to help 
those individuals who struggle with applying their improved motor skills in their daily 
communication after treatment.  
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